BPC
CNCE

Banque Pictet & Cie’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Banque Pictet & Cie’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-13,197
Closed -$166K – 536
2014
Q3 		$166K Sell
13,197
-378
-3% -$3.67K ﹤0.01% 436
2014
Q2 		$137K Buy
13,575
+2,029
+18% +$19.6K ﹤0.01% 446
2014
Q1 		$155K Buy
+11,546
New +$163K ﹤0.01% 405

Other funds holding CNCE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Banque Pictet & Cie's CNCE Position: Q4 2014 in Review

Banque Pictet & Cie sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q4 2014, closing a stake of 13,197 shares — an estimated $166K sold.

Banque Pictet & Cie first reported a position in CNCE in Q1 2014 and held it in 3 quarters. The position peaked at $166K in Q3 2014. 54 funds tracked by Wall St. Rank hold CNCE as of Q4 2014.

  • Banque Pictet & Cie reported no remaining Concert Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Banque Pictet & Cie sold 13,197 Concert Pharmaceuticals, Inc. shares in Q4 2014, an estimated $166K.
  • Banque Pictet & Cie first reported a position in Concert Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
  • Banque Pictet & Cie's Concert Pharmaceuticals, Inc. position peaked at $166K in Q3 2014.
  • 54 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2014.

Based on Banque Pictet & Cie's 13F filing for Q4 2014, filed 12 Feb 2015.